Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences to Host Its Fourth Quarter 2015 Earnings Results Conference Call on February 25, 2016
PLAINSBORO, N.J., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its fourth quarter 2015 financial results on Thursday, February 25, 2016. The company has scheduled a conference call for 4:30 PM ET the same day to discuss the results.
View HTML
Toggle Summary Integra LifeSciences Receives FDA Approval of Integra® Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU)
  PLAINSBORO, N.J., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that the United States Food and Drug Administration (FDA) has approved the PMA Supplement for Integra ® Dermal Regeneration Template (IDRT) for the treatment of diabetic
View HTML
Toggle Summary Integra LifeSciences to Present at the 34th Annual J.P. Morgan Healthcare Conference  In January 2016
PLAINSBORO, N.J., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the 34 th Annual J.P. Morgan Healthcare Conference: At 2:30PM PT on Wednesday, January 13, 2016, Mr. Peter Arduini, President and Chief Executive
View HTML
Toggle Summary Integra LifeSciences to Present at the 27th Annual Piper Jaffray Healthcare Conference and the Oppenheimer 26th Annual Healthcare Conference in December 2015
PLAINSBORO, N.J., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it will present at the following conferences in December: At 9:30AM ET on Tuesday, December 1, 2015, Mr. Peter Arduini, President and Chief Executive Officer, will
View HTML
Toggle Summary Integra LifeSciences Hosts Investor Day Today, November 12, 2015 in New York City
Increases 2018 Financial Outlook
View HTML
Toggle Summary Integra LifeSciences Reports Third Quarter 2015 Financial Results
Revenue Increased 14.6% to $226.4 Million with Adjusted EPS of $0.75 Adjusted Net Income Increased 15.1% Raised Low End of Full Year 2015 Revenue and EPS Guidance PLAINSBORO, N.J., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial
View HTML
Toggle Summary Integra LifeSciences Receives Expanded Indication for CUSA® Excel+ System for Liver Surgery
CUSA® Excel+ System is First and Only Ultrasonic Tissue Ablation System Cleared by FDA for Liver Surgery
View HTML
Toggle Summary Integra LifeSciences to Host Its Third Quarter 2015 Earnings Results Conference Call on November 3, 2015
Investor Day to be Held November 12, 2015 in New York City
View HTML
Toggle Summary Integra LifeSciences Completes Acquisition of Salto Talaris(R) Total Ankle Replacement and Futura(TM) Silastic Toe Replacement Product Portfolios from Tornier N.V.
PLAINSBORO, N.J., Oct. 2, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it closed the acquisition of the United States rights to Tornier's Salto Talaris® and Salto Talaris® XT ankle replacement products and Tornier's Futura™ silastic toe
View HTML
Toggle Summary Integra LifeSciences Files Patent Infringement Lawsuit Against HyperBranch Medical Technology, Inc.
PLAINSBORO, N.J., Sept. 15, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra filed a lawsuit in the U.S. District Court for the District of Delaware against HyperBranch Medical Technology, Inc.
View HTML